Burosumab-twza Subcutaneous and Carbidopa and levodopa enteral
Determining the interaction of Burosumab-twza Subcutaneous and Carbidopa and levodopa enteral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Carbidopa and Levodopa Enteral Suspension
- Burosumab-twza Subcutaneous-Carbidopa and Levodopa Extended-Release Capsules
- Burosumab-twza Subcutaneous-Carbidopa and Levodopa Extended-Release Tablets
- Burosumab-twza Subcutaneous-Carbidopa and Levodopa ODT
- Burosumab-twza Subcutaneous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Burosumab-twza Subcutaneous-Carbidopa and levodopa Route Not Applicable
- Carbidopa and levodopa enteral-Buspar
- Carbidopa and levodopa enteral-Buspar Dividose
- Carbidopa and levodopa enteral-Buspirone
- Carbidopa and levodopa enteral-Buspirone Hydrochloride
- Carbidopa and levodopa enteral-Busulfan
- Carbidopa and levodopa enteral-Busulfan Concentrate Injection